Topic: Melanoma.
Destination: The MRA and The Rising Tide Foundation for Clinical Cancer Research will jointly support two team awards for clinical trials with the potential to provide substantial impact to melanoma patients. These awards seek to support novel, interventional clinical trials with the goal of making a significant difference to melanoma patients in the short term. Patient engagement must be actively demonstrated throughout the full life cycle of the clinical trial, including planning and dissemination.
Budget: Up to $1,500,000. Co-funding is welcome. If the total cost of the trial exceeds $1,500,000, applicants must include a plan to secure the remainder of the funding to ensure the trial can be completed.
Duration: Up to 5 years.
Llena el siguiente formulario para recibir más información: